An open-label study of bioavailability of intranasally administered epinephrine in healthy adult subjects with seasonal allergies
Latest Information Update: 31 Mar 2023
At a glance
- Drugs Epinephrine (Primary) ; Epinephrine (Primary)
- Indications Anaphylaxis
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 28 Mar 2023 According to Bryn Pharma's media release, presented positive results from this study at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) annual meeting in Atlanta, GA.
- 28 Mar 2023 Results presented in a Bryn Pharma's Media Release.
- 23 Mar 2023 New trial record